Four-Strain Seasonal Flu Vaccine Approved in Korea

The health authority of South Korea has approved the first Korean-made vaccine to cover four influenza strains.

AsianScientist (Dec. 9, 2015) – South Korea’s Ministry of Food and Drug Safety has approved the first Korean influenza (flu) vaccine to cover four influenza strains. The GCFlu Quadrivalent for immunization of adults was made by Green Cross Corporation (Green Cross), a South Korean biopharmaceutical company.

Until recent years, seasonal flu vaccines included two A virus strains and only one B strain. GCFlu Quadrivalent adds coverage of a second B strain to help protect against flu disease.

“Green Cross is committed to providing new immunization option for the protection of flu, and we are excited to introduce GCFlu Quadrivalent as an important newest addition to the GCFlu which is administered to more than 100 million people in the world last 5 years,” said Dr. EC Huh, President of Green Cross Corporation.

GCFlu Quadrivalent will be available to the healthcare providers in South Korea for the 2016-2017 flu season in prefilled syringes for intramuscular administration.

———

Source: Green Cross; Photo: Daniel Paquet/Flickr/CC.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist